Inventor · disambiguated record
John F. Marcelletti
Also filed as: MARCELLETTI JOHN · MARCELLETTI JOHN F
7 granted patents·13 pending applications·264 citations·filing 1994–2006
88Inventor score
Files withSIKIC BRANIMIR8AVANIR PHARMACEUTICALS4SCHWEGMAN JEFF3LIDAK PHARMACEUTICALS2PROMETHEUS LAB INC2
Top patents by PatentIndex Score
20 records- 0192US5952392ALong-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibitionAVANIR PHARMACEUTICALS·Filed 1997·Granted Sep 14, 1999·144 cites·20 claims
- 0285US7759079B2Methods of diagnosing inflammatory bowel diseasePROMETHEUS LAB INC·Filed 2005·Granted Jul 20, 2010·24 cites·21 claims
- 0384US5534554ASucrose ester-C20 to C28 alcohol formulationsLIDAK PHARMACEUTICALS·Filed 1994·Granted Jul 9, 1996·54 cites·22 claims
- 0475US7091190B2Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogsAVANIR PHARMACEUTICALS·Filed 2002·Granted Aug 15, 2006·7 cites·31 claims
- 0557US5948822ATreatment of hyperproliferative skin disorders with C18 to C26 alphatic alcoholsLIDAK PHARMACEUTICALS·Filed 1997·Granted Sep 7, 1999·16 cites·7 claims
- 0655US2007010465A1Zosuquidar, daunorubicin, and cytarabine for the treatment of cancerSIKIC BRANIMIR·Filed 2006·Application pending·0 cites
- 0755US2007010466A1Zosuquidar, daunorubicin, and cytarabine for the treatment of cancerSIKIC BRANIMIR·Filed 2006·Application pending·0 cites
- 0855US2007010478A1Zosuquidar, daunorubicin, and cytarabine for the treatment of cancerSIKIC BRANIMIR·Filed 2006·Application pending·0 cites
- 0954US6440980B1Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogsAVANIR PHARMACEUTICALS·Filed 1999·Granted Aug 27, 2002·10 cites·46 claims
- 1052US2007009532A1Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidarSIKIC BRANIMIR·Filed 2006·Application pending·0 cites
- 1152US2007009531A1Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidarSIKIC BRANIMIR·Filed 2006·Application pending·0 cites
- 1248US6313179B1Treatment of hyperproliferative skin disorders with C18 to C20 aliphatic alcoholsAVANIR PHARMACEUTICALS·Filed 1998·Granted Nov 6, 2001·9 cites·7 claims
- 1345US2007010485A1Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrinsSCHWEGMAN JEFF·Filed 2006·Application pending·0 cites
- 1445US2007010487A1Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrinsSCHWEGMAN JEFF·Filed 2006·Application pending·0 cites
- 1545US2007010486A1Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrinsSCHWEGMAN JEFF·Filed 2006·Application pending·0 cites
- 1644US2007009533A1Treatment of cancer patients exhibiting activation of the P-glycoprotein efflux pump mechanismSIKIC BRANIMIR·Filed 2006·Application pending·0 cites
- 1743US2007009534A1Treatment of cancer patients exhibiting activation of the P-glycoprotein efflux pump mechanismSIKIC BRANIMIR·Filed 2006·Application pending·0 cites
- 1841US2004033982A1Viral inhibition by n-docosanolFiled 2002·Application pending·0 cites
- 1939US2006154276A1Methods of diagnosing inflammatory bowel diseasePROMETHEUS LAB INC·Filed 2005·Application pending·0 cites
- 2036US2007009535A1Treatment of cancer patients exhibiting activation of the P-glycoprotein efflux pump mechanismSIKIC BRANIMIR·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →